Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
2108030 | Cancer Cell | 2014 | 16 Pages |
•lncRNA-ATB is activated by TGF-β and associated with poor prognosis in HCC•lncRNA-ATB upregulates ZEB1 and ZEB2 through competitively binding miR-200s•lncRNA-ATB promotes EMT, HCC cell invasion, and metastatic organ colonization•lncRNA-ATB binds IL-11 mRNA, induces IL-11 expression, and triggers STAT3 signaling
SummaryThe role of TGF-β-induced epithelial-mesenchymal transition (EMT) in cancer cell dissemination is well established, but the involvement of lncRNAs in TGF-β signaling is still unknown. In this study, we observed that the lncRNA-activated by TGF-β (lncRNA-ATB) was upregulated in hepatocellular carcinoma (HCC) metastases and associated with poor prognosis. lncRNA-ATB upregulated ZEB1 and ZEB2 by competitively binding the miR-200 family and then induced EMT and invasion. In addition, lncRNA-ATB promoted organ colonization of disseminated tumor cells by binding IL-11 mRNA, autocrine induction of IL-11, and triggering STAT3 signaling. Globally, lncRNA-ATB promotes the invasion-metastasis cascade. Thus, these findings suggest that lncRNA-ATB, a mediator of TGF-β signaling, could predispose HCC patients to metastases and may serve as a potential target for antimetastatic therapies.